Page 92 - 《中国药房》2026年6期
P. 92

·药物与临床·


          肠道微生物群、血液代谢物与药物抗抑郁效应的因果关系研究
                                                                                                         Δ

                *
          娄琳琳 ,施玲怡,周湘君,蒋 颖,朱浩浩(江南大学附属精神卫生中心普通精神科,江苏 无锡 214151)
                                                #
          中图分类号  R971+.4;R749      文献标志码  A      文章编号  1001-0408(2026)06-0770-06
          DOI  10.6039/j.issn.1001-0408.2026.06.13

          摘   要  目的  从遗传学角度探究肠道微生物群、血液代谢物与抗抑郁效应之间的因果关系,并评估血液代谢物在其中可能发挥
          的中介作用。方法  采用双样本孟德尔随机化(MR)分析,基于4个大规模的肠道微生物组全基因组关联研究(GWAS)数据集和2
          个血液代谢物GWAS数据集,以逆方差加权法作为主要分析方法,评估肠道微生物群、血液代谢物与抗抑郁效应之间的因果关系,
          通过多种敏感性分析评估结果的稳健性、遗传异质性与水平多效性,并采用错误发现率(FDR)校正多重假设检验带来的Ⅰ型错
          误。通过MR中介分析评价血液代谢物的中介效应。结果  嗜胆菌属菌种与抗抑郁治疗有效呈显著负相关(P=8.030×10 ,FDR
                                                                                                        -5
          校正后P=0.033),而拟杆菌目菌科与抗抑郁治疗有效呈显著正相关(P=3.275×10 ,FDR校正后P=0.034);筛选出百余个与抗
                                                                          -4
          抑郁效应相关的血液代谢物,但经FDR校正后显示,均无显著因果关系;血液代谢物在“肠道微生物群-血液代谢物-抗抑郁效应”
          路径中的中介效应比值的P均大于0.05。结论  嗜胆菌属菌种可能是抗抑郁效应的危险性因素,拟杆菌目菌科则可能是抗抑郁效
          应的保护性因素。血液代谢物与抗抑郁效应的相关性不强,且尚无遗传学证据表明血液代谢物可在肠道微生物群与抗抑郁效应
          之间发挥关键中介作用。
          关键词  肠道微生物群;血液代谢物;抗抑郁效应;孟德尔随机化分析;中介分析


          Study  on  the  causal  relationship  between  gut  microbiota,  blood  metabolites  and  antidepressant  treatment
          response
          LOU Linlin,SHI Lingyi,ZHOU Xiangjun,JIANG Ying,ZHU Haohao(Dept.  of  General  Psychiatry,  the
          Affiliated Mental Health Center of Jiangnan University, Jiangsu Wuxi 214151, China)

          ABSTRACT    OBJECTIVE  To  investigate  the  causal  relationships  between  gut  microbiota,  blood  metabolites  and  antidepressant
          treatment  response  from  a  genetic  perspective,  and  to  assess  the  potential  mediating  role  of  blood  metabolites.  METHODS  This
          study  utilized  a  two-sample  Mendelian  randomization (MR)  design.  Exposure  data  were  derived  from  four  large-scale  gut
          microbiome  genome-wide  association  study (GWAS)  datasets  and  two  blood  metabolite  GWAS  datasets.  The  inverse  variance
          weighted  method  was  used  as  the  primary  method  to  evaluate  the  causal  relationships  between  gut  microbiota,  blood  metabolites
          and  antidepressant  effects.  The  robustness,  heterogeneity  and  horizontal  pleiotropy  of  the  results  were  evaluated  through  various
          sensitivity  analyses.  Additionally,  the  false  discovery  rate (FDR)  was  applied  to  correct  type  Ⅰ  errors  caused  by  multiple
          hypothesis  testing.  Finally,  MR  mediation  analysis  was  conducted  to  test  the  potential  mediating  effect  of  blood  metabolites.
          RESULTS The s_Bilophila was negatively associated with the effectiveness of antidepressant treatment (P=8.030×10 , then P=
                                                                                                    -5
          0.033  after  FDR  correction),  and  the  f_Bacteroidales  was  positively  associated  with  the  effectiveness  of  antidepressant  treatment
         (P=3.275×10 ,  then  P=0.034  after  FDR  correction).  Over  a  hundred  blood  metabolites  were  also  screened  out  as  being
                      -4
          associated  with  antidepressant  response,  but  after  FDR  correction,  no  significant  causal  relationship  was  observed. The  P  value  of
          the  mediation  effect  proportion  of  blood  metabolites  in  the “gut  microbiota-blood  metabolites-antidepressant  efficacy”  pathway  was
          greater  than  0.05.  CONCLUSIONS  The  s_Bilophila  may  represent  a  risk  factor  for  antidepressant  effects,  whereas  the
          f_Bacteroidales  may  serve  as  a  protective  factor  for  antidepressant  effects.  The  correlation  between  blood  metabolites  and
                                                              antidepressant  efficacy  is  not  strong,  and  no  genetic  evidence
              Δ 基金项目 国家自然科学基金面上项目(No.82571738);江苏省            is found to support that the investigated blood metabolites play
          自然科学基金面上项目(No.BK20251755)                           a  key  mediating  role  between  the  gut  microbiota  and
             * 第一作者 硕 士 研 究 生 。 研 究 方 向 :精 神 病 学 。 E-mail:
                                                              antidepressant response.
          17551303047@163.com
              # 通信作者 副研究员,硕士生导师,博士。研究方向:精神病学。                 KEYWORDS    gut  microbiota;  blood  metabolites;  antidepressant
          E-mail:zhuhh@jiangnan.edu.cn                        response; Mendelian randomization analysis; mediation analysis


          · 770 ·    China Pharmacy  2026 Vol. 37  No. 6                               中国药房  2026年第37卷第6期
   87   88   89   90   91   92   93   94   95   96   97